Pennant Group (PNTG) vs GeneDx (WGS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Pennant Group (PNTG) has outperformed GeneDx (WGS) over the past year, gaining 59.6% versus a loss of 44.8%. Over five years, PNTG leads with a +55.6% price change compared with -73.7% for WGS. GeneDx is the larger company by market cap ($2.01 billion vs $1.39 billion), about 1.4 times the size.
On valuation, Pennant Group trades at a lower forward P/E (25.0x vs 56.2x for GeneDx).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PNTG | WGS |
|---|---|---|
| Share price | $39.73 | $67.33 |
| Market cap | $1.39B | $2.01B |
| 1-day change | -1.59% | -0.59% |
| YTD return | +43.41% | -47.92% |
| 1-year return | +59.63% | -44.80% |
| 5-year return | +55.63% | -73.65% |
| P/E ratio (TTM) | 43.66 | — |
| Forward P/E | 25.03 | 56.18 |
| EPS (TTM) | $0.91 | $-3.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $427.54M |
| Revenue growth (YoY) | — | +39.97% |
| Net income (latest FY) | — | $-21.02M |
| Gross margin | — | 69.74% |
| Operating margin | — | -3.06% |
| Net margin | — | -4.92% |
| 52-week high | $42.74 | $170.87 |
| 52-week low | $22.26 | $32.21 |
| Distance from 52-week high | -7.04% | -60.60% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +17.87% | +38.87% |
| Average volume | 314.35K | 730.21K |
| Shares outstanding | 34.93M | 29.82M |
| Employees | 9,700 | 1,300 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PNTG has outperformed WGS by 104.4 percentage points over the past year.
About Pennant Group
PNTG stock →The Pennant Group, Inc. provides healthcare services in the United States.
Health Care · Medical/Nursing Services · 9,700 employees
About GeneDx
WGS stock →GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
Health Care · Medical/Nursing Services · 1,300 employees
PNTG vs WGS FAQ
Which is bigger, Pennant Group or GeneDx?
GeneDx (WGS) is larger, with a market capitalization of $2.01B compared with $1.39B for Pennant Group (PNTG).
Which stock has performed better over the past year, PNTG or WGS?
PNTG returned +59.63% over the past 12 months, compared with -44.80% for WGS (price return, excluding dividends). Past performance does not predict future results.
Are Pennant Group and GeneDx in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.